Yao Ming Kang De (02359) suggests adopting the 2024 H share incentive trust plan
Yao Ming Kangde (02359) issued an announcement. The board of directors met at the board meeting held on April 29, 2024...
藥明康德:2024年第一季度報告
1Q Rev $7.98B >2359.HK
1Q Rev $7.98B >2359.HK
1Q EPS 66c >2359.HK
1Q EPS 66c >2359.HK
Yao Ming Kangde (02359.HK) spent 2005 million yuan to buy back 452,100 A shares on April 29
Gelonghui, April 29, 丨 Yao Ming Kangde (02359.HK) issued an announcement. On April 29, 2024, it spent RMB 2005 million yuan to buy back 452,100 A shares, with a repurchase price of 42.95-45.01 yuan per share.
藥明康德:2023年度報告
On April 26, Yao Ming Kangde (02359.HK) spent 2005 million yuan to buy back 475,500 A shares
Gelonghui, April 26, 丨 Yao Ming Kangde (02359.HK) issued an announcement. On April 26, 2024, it spent RMB 2005 million yuan to buy back 475,500 A shares, with a repurchase price of 41.32-43.11 yuan per share.
Yao Ming Kangde (02359) spent 2.047,800 yuan to buy back 475,500 A shares on April 26
Yao Ming Kangde (02359) announced that on April 26, 2024, the company spent 2.047,800 yuan to buy back 475,500 A-shares.
Trending Industry Today: TIGERMED Leads Gains In Pharmaceutical Outsourcing/contract Research Organization(cro Concept) Stocks
April 26th - The industry of $Pharmaceutical Outsourcing/contract Research Organization(cro Concept)(BK1261.HK)$ is trending higher today with 8 constituents up and TIGERMED leading Gains.$TIGERMED(03
Changes in Hong Kong stocks | Tiger Pharmaceuticals (03347) rose more than 8% to lead CRO concept stocks, reports say the national level is expected to introduce an action plan for the biological manufacturing industry in the near future
CRO concept stocks increased their gains in the afternoon. As of press release, Tiger Pharmaceuticals (03347) rose 8.39% to HK$33.6; Kanglong Chemical (03759) rose 7.16% to HK$9.43; Pharmaceutical Biotech (02269) rose 6.75% to HK$13.6; and Pharmaceuticals (02359) rose 4.74% to HK$35.35.
Will Weakness in WuXi AppTec Co., Ltd.'s (SHSE:603259) Stock Prove Temporary Given Strong Fundamentals?
WuXi AppTec (SHSE:603259) has had a rough three months with its share price down 37%. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually d
Yao Ming Kangde (02359.HK) spent 2005 million yuan to buy back 479,000 A shares on April 25
On April 25, Ge Longhui | Yao Ming Kangde (02359.HK) issued an announcement. On April 25, 2024, it spent RMB 2005 million yuan to repurchase 479,000 A shares, with a repurchase price of 41.6-42.39 yuan per share.
Yao Ming Kangde (02359) spent 2.046,800 yuan to buy back 475,800 A shares on April 24
Yao Ming Kangde (02359) issued an announcement to repurchase 475,800 A-shares with RMB 2.046,800 on April 24, 2024.
Global Clinical Trials Market Analysis, Size, and Forecasts 2023 and 2024-2030 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, Sanofi, and Medpace - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Clinical Trials Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to Research
Yao Ming Kangde (02359) spent about 2.048,000 yuan to buy back 475,700 A shares on April 23
Yao Ming Kangde (02359) announced that on April 23, 2024, it cost about 2.048,000 yuan to buy back 47.5...
Yao Ming Kangde (02359.HK) spent 2005 million yuan to buy back 474,200 A shares on April 19
On April 19, Ge Longhui (02359.HK) issued an announcement. On April 19, 2024, it spent RMB 2005 million yuan to buy back 474,200 A shares, with a repurchase price of 41.88-42.9 yuan per share.
Trending Industry Today: GENSCRIPT BIO Leads Losses In Pharmaceutical Outsourcing/contract Research Organization(cro Concept) Stocks
April 19th - The industry of $Pharmaceutical Outsourcing/contract Research Organization(cro Concept)(BK1261.HK)$ is trending lower today with 9 constituents down and GENSCRIPT BIO leading Losses.$GENS
Changes in Hong Kong stocks | CRO concept stocks continue to decline, the Federal Reserve does not rule out possible interest rate hikes, domestic innovative drugs are still in an adjustment cycle
The Zhitong Finance App learned that CRO concept stocks continued to decline. As of press release, Tiger Pharmaceuticals (03347) fell 7.94% to HK$28.4; Kingsley Biotech (01548) fell 5.93% to HK$10.78; Kanglong Chemical (03759) fell 4.83% to HK$8.47; and Pharmaceuticals (02359) fell 4.5% to HK$32.9. According to the news, overnight, Federal Reserve officials made hawkish remarks. New York Federal Reserve Chairman Williams said that if the data reminds us that we need to raise interest rates to achieve our goals, then we will obviously do it. Furthermore, Asia
Yao Ming Kangde (02359) spent 2.047,900 yuan to buy back 458,600 A shares on April 18
Yao Ming Kangde (02359) announced that on April 18, 2024, the company spent RMB 2004...
Yao Ming Kangde (02359) spent 20048,200 yuan to buy back 477,400 A shares on April 17
Yao Ming Kangde (02359) announced that on April 17, 2024, the company spent RMB 2004...
No Data